The binding of PD-1 ligands to PD-1 inactivates T cell responses to the cells presenting these ligands, i.e., the pancreatic cancer cells and stroma in this situation, facilitating the cancer to escape from the host’s immune surveillance [101]. This evidence concerns the gene PDCD1 and pancreatic neoplasm.